n(6)-carboxymethyllysine has been researched along with Diabetic Neuropathies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubert, CE; Bourron, O; Fonfrede, M; Gillery, P; Hartemann, A; Jaisson, S; Michel, PL; Morel, F | 1 |
| Bierhaus, A; Haslbeck, KM; Haslbeck, M; Heuss, D; Nawroth, P; Neundörfer, B; Schleicher, E | 1 |
| Hamada, Y; Horiuchi, S; Hotta, N; Kasuya, Y; Kato, K; Komori, T; Nagai, R; Nakamura, J; Naruse, K | 1 |
| Schmidt, AM; Stern, DM; Yan, SD; Yan, SF | 1 |
| Friess, U; Haslbeck, KM; Heuss, D; Kirchner, A; Neundörfer, B; Schleicher, ED | 1 |
1 review(s) available for n(6)-carboxymethyllysine and Diabetic Neuropathies
| Article | Year |
|---|---|
The biology of the receptor for advanced glycation end products and its ligands.
Topics: Amyloidosis; Animals; Capillary Permeability; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Endothelium, Vascular; Erythrocytes; Glycation End Products, Advanced; Humans; Ligands; Lung; Lysine; Membrane Proteins; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Serum Amyloid A Protein; Tumor Cells, Cultured | 2000 |
4 other study(ies) available for n(6)-carboxymethyllysine and Diabetic Neuropathies
| Article | Year |
|---|---|
Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes.
Topics: Aged; Arterial Occlusive Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Paris; Peripheral Nervous System; Prevalence; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Risk Factors; Severity of Illness Index; Sex Factors; Solubility; Waist Circumference | 2014 |
The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).
Topics: Aged; Biopsy; Charcot-Marie-Tooth Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glucose Intolerance; Glycation End Products, Advanced; Humans; Lysine; Middle Aged; NF-kappa B; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Sural Nerve | 2005 |
Epalrestat, an aldose reductase ihibitor, reduces the levels of Nepsilon-(carboxymethyl)lysine protein adducts and their precursors in erythrocytes from diabetic patients.
Topics: Aldehyde Reductase; Blood Glucose; Blood Proteins; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Erythrocytes; Female; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Reference Values; Rhodanine; Thiazolidines | 2000 |
N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies.
Topics: Adult; Aged; Biopsy; Blotting, Western; Charcot-Marie-Tooth Disease; Diabetic Neuropathies; Female; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Oxidative Stress; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Sural Nerve | 2002 |